IP Verse

An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent Diseases - EP3574907

The patent EP3574907 was granted to Kandy Therapeutics on Aug 23, 2023. The application was originally filed on May 16, 2016 under application number EP19186140A. The patent is currently recorded with a legal status of "Revoked".

EP3574907

KANDY THERAPEUTICS
Application Number
EP19186140A
Filing Date
May 16, 2016
Status
Revoked
Feb 7, 2025
Grant Date
Aug 23, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AERAMay 23, 2024ADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2004056799
DESCRIPTIONWO2004056805
DESCRIPTIONWO2005002577
DESCRIPTIONWO2005097794
DESCRIPTIONWO2006013050
DESCRIPTIONWO2007028654
DESCRIPTIONWO2008128891
DESCRIPTIONWO2011023733
DESCRIPTIONWO2011031571
DESCRIPTIONWO2011131571
SEARCHWO02089802
SEARCHWO2005002577
SEARCHWO2005097774
SEARCHWO2007028654
SEARCHWO2011023733

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BERTRANDGEPPETTI, Trends Pharmacol. Sci., (19960000), vol. 17, pages 255 - 259-
DESCRIPTION- Inactive Ingredient Guide, U.S. Food and Drug Administration (FDA) Center for Drug-
EXAMINATION- Anon., "ICD-11 for Mortality and Morbidity Statistics : GA20.50 Heavy menstrual bleeding", (20190401), URL: https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f609833590, (20230131), XP093019520-
EXAMINATION- DOMINIQUE DE ZIEGLER ET AL, "Inflammation and uterine fibrosis: the possible role of chronic endometritis", FERTILITY AND STERILITY, AMSTERDAM, NL, (20190501), vol. 111, no. 5, doi:10.1016/j.fertnstert.2019.02.005, ISSN 0015-0282, pages 890 - 891, XP055724527
SEARCH- CATERINA BISSANTZ ET AL, "Identification of a Crucial Amino Acid in the Helix Position 6.51 of Human Tachykinin Neurokinin 1 and 3 Receptors Contributing to the Insurmountable Mode of Antagonism by Dual NK 1 /NK 3 Antagonists", JOURNAL OF MEDICINAL CHEMISTRY, US, (20120614), vol. 55, no. 11, doi:10.1021/jm2017072, ISSN 0022-2623, pages 5061 - 5076, XP055234123 [A] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents